2073
We report a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1 who developed severe motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of vincristine.
 ( adverse event: developed ,  a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1: Subject, 31-year-old: Subject.Age, women: Subject.Gender, unrecognized HMSN-1: Subject.Disorder, severe motor neuropathy: Effect, 3 weeks after the first cycle of treatment including 2 mg of vincristine: Treatment, recurrent Hodgkin's lymphoma: Treatment.Disorder, 3 weeks: Treatment.Time_elapsed, 2 mg: Treatment.Dosage, vincristine: Treatment.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1: Subject, 31-year-old: Subject.Age, women: Subject.Gender, unrecognized HMSN-1: Subject.Disorder, severe motor neuropathy: Effect, 3 weeks after the first cycle of treatment including 2 mg of vincristine: Treatment, recurrent Hodgkin's lymphoma: Treatment.Disorder, 3 weeks: Treatment.Time_elapsed, 2 mg: Treatment.Dosage, vincristine: Treatment.Drug) 